Tuesday, 6 December 2016
Interested in the latest research into how technology can help people? Then please keep visiting this blog or take a look at the CATCH website. CATCH stands for the Centre for Assistive Technology and Connected Healthcare and consists of a large group of people who work across multiple departments at the University of Sheffield. You can visit their website here: http://www.catch.org.uk
Monday, 5 December 2016
A job opportunity has arisen within the University of Sheffield's School of Health and Related Research (ScHARR), Design Trials and Statistics, for a Trials Support Officer.
Post Ref - UOS014997Salary £18,212 - £20,400 per annum pro-rataClosing Date - Monday 19th December
This post is fixed term for 12 months
Please visit the University Jobs website for further details: http://www.sheffield.ac.uk/jobs
Wednesday, 30 November 2016
A five day congress otherwise known as the AAATE will be coming to Sheffield in September 2017. The congress will be hosted by the University of Sheffield. The call for papers is now open and submissions can be made from 14th December 2016 with a deadline of January 2017.
For more details please visit the AAATE website: http://www.aaate2017.eu
Tuesday, 29 November 2016
One dark and damp evening last month two members of the CATCH team decided to venture out across the Peak District to take part in a fantastic event organised by Sound and Music Charity as part of the Design Manchester 2016 Festival.
Translational Researchers Dr Katherine Easton and Dr Stephen Potter took part in the latest Creative Data Club, one of a series of regular ‘datagazing’ events, which had relocated specially for the Festival from its safe London home to the trendy Texture bar in the heart of Manchester’s bustling Northern Quarter. The event brought together speakers from a range of backgrounds to share their projects, working practices and thoughts with an audience of artists, scientists and general creative types.
The event was run in partnership with information design agency Signal Noise, and addressed the theme of design and diversity – more specifically, how might we diversify audiences, experiences and accessibility by using data and design in open and inclusive ways. Katherine discussed the importance of co-production with end users to the success of assistive technology projects, with Stephen presenting ways in which data and design processes can mislead and exclude the very people we try to assist. The other speakers talked about designing adapted musical instruments, inclusive musical theatre and composition, and wider issues of data privacy and data inequality. All in all, a fascinating evening that provided insights into the practices and concerns of communities beyond the usual reach of CATCH public engagement exercises.
Monday, 28 November 2016
Friday, 25 November 2016
Takeda is enlisting data integration player Koneksa Health on a scheme to bring new digital health tools to its clinical trials. The partnership will see Takeda using Koneksa’s remote data collection capabilities in trials for multiple pipeline candidates.
The goal of the tie-up is to develop “digital biomarkers” that could support decision-making and eventually contribute to new endpoints that will improve the assessment of patients in their natural environment, according to a statement.
The Japanese pharma will use Koneksa’s platform to integrate biosensors and wearables in a number of early-stage clinical trials, according to the statement. The technology facilitates the collection of patient-generated data that were previously tricky to obtain, such as patients’ continuous vital signs, activity levels and sleep metrics, Takeda said.
Thursday, 24 November 2016
Owlet Baby Care just boosted its total capital raised to $25 million, thanks to a new $15 million in venture financing and an NIH grant. The new infusion will drive the international distribution efforts of its baby monitor that alerts parents via smartphone app if their baby stops breathing.
The Owlet baby monitor comprises a sensor-embedded smart sock, a base station and a smartphone app. The smart sock monitors the infant’s heart rate and oxygen levels using pulse oximetry and communicates this data to the base station via bluetooth. If the child’s heart rate is too low or too high, or if his or her oxygen level falls below a preset threshold, the base station and smartphone app will sound an alert. In 2017, the company expects to launch a feature allowing users more access to these data as well as the ability to share it with pediatricians, according to a statement.
Click here to find out more.
Click here to find out more.
Wednesday, 23 November 2016
FDA has given 510(k) clearance to EOS Imaging’s 3D planning software for total knee arthroplasties. The green light continues the run of regulatory successes for EOS, which has now secured the OK to sell its full suite of EOSapps in the U.S.
KneeEOS, the latest app to receive FDA clearance, is the last step in a process that turns front and side-on images from a system sold by EOS into 3D models surgeons can use to plan knee operations. The 3D models generated by EOS’ team and rendered in kneeEOS allow surgeons to choose the size of implant needed for an operation and assess its positioning before starting a procedure. KneeEOS suggests the most appropriate implant and position based on the model.
Tuesday, 22 November 2016
Ava, which focuses on women’s reproductive health, reeled in a $9.7 million Series A funding round, which will drive product development and scale production of its fertility-tracking wristband, as well as propel its expansion into European markets.
The Zurich-based company launched the Ava fertility bracelet in the U.S. in July. It is the first device to track the fertile days of a woman’s menstrual cycle in real time, according to the company.
Worn at night, the device continuously records data on nine physiological measures that reflect a rise in hormones associated with ovulation, according to a statement from the company. These measures include pulse, breathing rate, sleep quality and temperature. In the morning, the data is synced with a mobile app. A recent study showed the tracker was able to identify an average of 5.3 fertile days per cycle with 89 percent accuracy.
Monday, 21 November 2016
Voice analysis specialist Beyond Verbal and Mayo Clinic unveiled results from a new study demonstrating a strong correlation between some voice characteristics and the presence of coronary artery disease (CAD).
Beyond Verbal, which bills itself as an emotions analytics company, focuses on extracting as much information as possible from the tone of voice of a speaker, said CEO Yuval Mor. Voice analysis may be used to understand emotions and well-being, he said. We can tell with the human ear, for example, if a person is feeling well or not. The new study data confirms that we can also understand a medical condition by using voice feature analysis.
The double-blind study involved 120 patients who had been referred for elective coronary angiography and 120 control patients. Beyond Verbal provided Mayo Clinic with acoustic features, and the latter zeroed in on some characteristics that could “strongly and independently” be associated with CAD, Mor said. In particular, one feature was linked to a 19-fold higher likelihood of CAD, the companies said in a statement.